Insiders · Profile

Bumpus Namandje

Director at RECURSION PHARMACEUTICALS. Filing since 3 Jun 2026. CIK 0002060594

Company

Date

Role

Action

Shares

Amount

Of holding

RXRX RECURSION PHARMACEUTICALS, INC.

18 Jun 2026

Director

Sold on a plan

3,963

$12.60K

3.0%

RXRX RECURSION PHARMACEUTICALS, INC.

3 Jun 2026

Director

Sold on a plan

4,386

$15.53K

9.2%

2 decisions on file.